JPTCCM
AGTC

J.P. Turner & Co Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

J.P. Turner & Co Capital Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,500
Closed -$162K – 232
2015
Q2 		$162K Buy
+10,500
New +$201K 0.13% 200

Other funds holding AGTC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

J.P. Turner & Co Capital Management's AGTC Position: Q3 2015 in Review

J.P. Turner & Co Capital Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2015, closing a stake of 10,500 shares — an estimated $162K sold.

J.P. Turner & Co Capital Management first reported a position in AGTC in Q2 2015 and held it in 1 quarter. The position peaked at $162K in Q2 2015. 60 funds tracked by Wall St. Rank hold AGTC as of Q3 2015.

  • J.P. Turner & Co Capital Management reported no remaining Applied Genetic Technologies Corporation position as of Q3 2015 after selling out during the quarter.
  • J.P. Turner & Co Capital Management sold 10,500 Applied Genetic Technologies Corporation shares in Q3 2015, an estimated $162K.
  • J.P. Turner & Co Capital Management first reported a position in Applied Genetic Technologies Corporation in Q2 2015 and held it in 1 quarter.
  • J.P. Turner & Co Capital Management's Applied Genetic Technologies Corporation position peaked at $162K in Q2 2015.
  • 60 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2015.

Based on J.P. Turner & Co Capital Management's 13F filing for Q3 2015, filed 4 Nov 2015.